Prepared or at-risk? Evaluating live viral vaccine coverage and vaccine immunogenicity before pediatric solid organ transplantation
Transplant International · 29.07.2026 · 39
DOI: 10.3389/ti.2026.15958 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplant International, online erschienen am 29.07.2026. Verfasst von Benhur Sirvan Cetin und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Infectious Diseases, Faculty of Medicine, Erciyes University, Kayseri, Türkiye. Hauptthemen laut MEDLINE: Organ Transplantation, Chickenpox, Immunogenicity, Vaccine, Measles. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Pediatric solid organ transplant recipients are at high risk for complications from vaccine-preventable diseases, yet pre-transplant vaccination coverage is often inconsistent. We conducted a retrospective cohort study of 421 pediatric transplant recipients between 2018 and 2024 to evaluate vaccination status and serologic immunity for varicella and measles at the time of initial evaluation, listing, and transplantation. At the time of transplant, 19.2% of patients for varicella and 21.6% for measles were under-vaccinated, with infants having the highest rates of incomplete vaccination. A portion of patients (7.1% for varicella, 8.6% for measles) transitioned from full to incomplete vaccination status during the pre-transplant period, a change associated with a shorter time from evaluation to listing. Kidney recipients had the highest completed vaccination rates (>94%), whereas rates for liver and heart recipients were substantially lower (58%–72%). Among fully vaccinated patients, seronegativity was observed for varicella (23.6%) and measles (13.0%). In conclusion, many pediatric transplant candidates, particularly infants and those awaiting liver or heart transplant, are incompletely vaccinated. A dynamic change in vaccination status from evaluation to transplant highlights an urgent need for continuous monitoring and improved strategies to protect these vulnerable children.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Infectious Diseases, Faculty of Medicine, Erciyes University, Kayseri, Türkiye.
- Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.
- Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, United States.
- Department of Transplant Administration, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.
- Division of Infectious Diseases, University of Cincinnati Department of Internal Medicine, Cincinnati, OH, United States.
- Department of Liver and Intestinal Transplant, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.
Zitieren
APA
Cetin, B. S., Brammer, C., Otto, W., Perkins, K., Ambrosino, T., Miller-Handley, H., Murphy, M., Paulsen, G., Cain, E., Campbell, K., & Danziger-Isakov, L. (2026). Prepared or at-risk? Evaluating live viral vaccine coverage and vaccine immunogenicity before pediatric solid organ transplantation. Transplant International, 39. https://doi.org/10.3389/ti.2026.15958
Vancouver
Cetin BS, Brammer C, Otto W, Perkins K, Ambrosino T, Miller-Handley H, et al. Prepared or at-risk? Evaluating live viral vaccine coverage and vaccine immunogenicity before pediatric solid organ transplantation. Transplant International. 2026;39. doi:10.3389/ti.2026.15958
BibTeX
@article{Cetin2026,
author = {Cetin, Benhur Sirvan and Brammer, Caitlin and Otto, William and Perkins, Kerrigan and Ambrosino, Teresa and Miller-Handley, Hilary and Murphy, Mark and Paulsen, Grant and Cain, Emily and Campbell, Kathleen and Danziger-Isakov, Lara},
title = {Prepared or at-risk? Evaluating live viral vaccine coverage and vaccine immunogenicity before pediatric solid organ transplantation},
journal = {Transplant International},
year = {2026},
volume = {39},
doi = {10.3389/ti.2026.15958}
}
EUVIMED